A Healthcare group Verita, has planned investment in three digital healthcare businesses across Asia and Europe as part of its international expansion plan. The investment plan still has been not revealed, but according to a spokesperson from Verita, the company is planning to invest $50-60M.
Celli Health, Hanako and nBuddy are the organizations acquired by Verita. Celli Health is a digital health and wellness platform. Hanako is a company which provides a range of market-leading AI-driven mobile health screening solutions and nBuddy, a chronic disease management app; The three investments will be incorporated into the Verita Wisdom platform which offers a variety of tools to enable us for the early detection, prevention, management and reversal of chronic diseases. The most significant developments have been seen with Celli Health, which has now been rebranded as Verita Wellness. The platform has added new features since the acquisition, including challenges and incentives designed to encourage the user to actively participate in healthier lifestyle behavior changes.
The app will launch in Singapore at the end of 2019 to select Verita clients, including employees and patients of the company’s insurance and healthcare partners. In early 2020 it will expand to other international markets and be extended to customers of Verita’s commercial partners. The long-term plan is to make the platform available through public health bodies. Likewise, Hanako’s platform is being rolled out in Verita clinics and is being offered as an on-site service to corporate partners.